Hussain M, Das S, Kulkarni M, Laha S
Cell Oncol (Dordr). 2024; 47(5):1607-1626.
PMID: 39283476
DOI: 10.1007/s13402-024-00988-w.
Teng F, Cui T, Zhou L, Gao Q, Zhou Q, Li W
Signal Transduct Target Ther. 2024; 9(1):7.
PMID: 38167329
PMC: 10761793.
DOI: 10.1038/s41392-023-01680-5.
Pogozheva I, Cherepanov S, Park S, Raghavan M, Im W, Lomize A
J Chem Inf Model. 2023; 63(18):5874-5895.
PMID: 37694948
PMC: 11791896.
DOI: 10.1021/acs.jcim.3c00926.
Pegka F, Ben-Califa N, Neumann D, Jakel H, Hengst L
Cells. 2023; 12(13).
PMID: 37443738
PMC: 10340229.
DOI: 10.3390/cells12131704.
Pogozheva I, Cherepanov S, Park S, Raghavan M, Im W, Lomize A
bioRxiv. 2023; .
PMID: 37398331
PMC: 10312770.
DOI: 10.1101/2023.06.14.544971.
Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.
Defour J, Leroy E, Dass S, Balligand T, Levy G, Brett I
Elife. 2023; 12.
PMID: 37338955
PMC: 10313314.
DOI: 10.7554/eLife.81521.
JAK inhibitors and COVID-19.
Levy G, Guglielmelli P, Langmuir P, Constantinescu S
J Immunother Cancer. 2022; 10(4).
PMID: 35459733
PMC: 9035837.
DOI: 10.1136/jitc-2021-002838.
Molecular and cellular factors determining the functional pleiotropy of cytokines.
McFarlane A, Pohler E, Moraga I
FEBS J. 2022; 290(10):2525-2552.
PMID: 35246947
PMC: 10952290.
DOI: 10.1111/febs.16420.
Erythropoietin Non-hematopoietic Tissue Response and Regulation of Metabolism During Diet Induced Obesity.
Dey S, Lee J, Noguchi C
Front Pharmacol. 2021; 12:725734.
PMID: 34603036
PMC: 8479821.
DOI: 10.3389/fphar.2021.725734.
Erythropoietin regulation of red blood cell production: from bench to bedside and back.
Bhoopalan S, Huang L, Weiss M
F1000Res. 2020; 9.
PMID: 32983414
PMC: 7503180.
DOI: 10.12688/f1000research.26648.1.
Cytokine receptor splice variants in hematologic diseases.
Wang B, Mehta H
Cytokine. 2019; 127:154919.
PMID: 31816579
PMC: 6995764.
DOI: 10.1016/j.cyto.2019.154919.
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1.
Liau N, Laktyushin A, Morris R, Sandow J, Nicola N, Kershaw N
Cancers (Basel). 2019; 11(11).
PMID: 31683831
PMC: 6896158.
DOI: 10.3390/cancers11111701.
Transmembrane Protein Aptamer Induces Cooperative Signaling by the EPO Receptor and the Cytokine Receptor β-Common Subunit.
He L, Cohen E, Edwards A, Xavier-Ferrucio J, Bugge K, Federman R
iScience. 2019; 17:167-181.
PMID: 31279934
PMC: 6614117.
DOI: 10.1016/j.isci.2019.06.027.
Computational analysis of ligand-receptor interactions in wild-type and mutant erythropoietin complexes.
Pekas N, Newton S
Adv Appl Bioinform Chem. 2018; 11:1-8.
PMID: 30410371
PMC: 6197206.
DOI: 10.2147/AABC.S177206.
Mapping Determinants of Cytokine Signaling via Protein Engineering.
Gorby C, Martinez-Fabregas J, Wilmes S, Moraga I
Front Immunol. 2018; 9:2143.
PMID: 30319612
PMC: 6170656.
DOI: 10.3389/fimmu.2018.02143.
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation.
Ferrao R, Wallweber H, Lupardus P
Elife. 2018; 7.
PMID: 30044226
PMC: 6078494.
DOI: 10.7554/eLife.38089.
New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.
Pasquier F, Marty C, Balligand T, Verdier F, Grosjean S, Gryshkova V
Haematologica. 2017; 103(4):575-586.
PMID: 29269524
PMC: 5865417.
DOI: 10.3324/haematol.2017.176370.
Bi-directionally protective communication between neurons and astrocytes under ischemia.
Wu X, Qian C, Zhou Y, Yan Y, Luo Q, Yung W
Redox Biol. 2017; 13:20-31.
PMID: 28551085
PMC: 5447396.
DOI: 10.1016/j.redox.2017.05.010.
Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers.
Moraga I, Spangler J, Mendoza J, Gakovic M, Wehrman T, Krutzik P
Elife. 2017; 6.
PMID: 28498099
PMC: 5429090.
DOI: 10.7554/eLife.22882.
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions.
Ferrao R, Lupardus P
Front Endocrinol (Lausanne). 2017; 8:71.
PMID: 28458652
PMC: 5394478.
DOI: 10.3389/fendo.2017.00071.